These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 33729898)

  • 1. Newer anti-diabetic therapies with low hypoglycemic risk-potential advantages for frail older people.
    Emmerton D; Abdelhafiz A
    Hosp Pract (1995); 2021 Aug; 49(3):164-175. PubMed ID: 33729898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sex Differences in Cardiovascular Effectiveness of Newer Glucose-Lowering Drugs Added to Metformin in Type 2 Diabetes Mellitus.
    Raparelli V; Elharram M; Moura CS; Abrahamowicz M; Bernatsky S; Behlouli H; Pilote L
    J Am Heart Assoc; 2020 Jan; 9(1):e012940. PubMed ID: 31902326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New Agents for the Treatment of Type 2 Diabetes.
    Libianto R; Ekinci EI
    Crit Care Clin; 2019 Apr; 35(2):315-328. PubMed ID: 30784612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of Type 2 Diabetes in Frail Older Adults.
    Bahat G; Ozkok S; Petrovic M
    Drugs Aging; 2023 Sep; 40(9):751-761. PubMed ID: 37434085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycemic efficacy and safety of glucagon-like peptide-1 receptor agonist on top of sodium-glucose co-transporter-2 inhibitor treatment compared to sodium-glucose co-transporter-2 inhibitor alone: A systematic review and meta-analysis of randomized controlled trials.
    Patoulias D; Stavropoulos K; Imprialos K; Katsimardou A; Kalogirou MS; Koutsampasopoulos K; Zografou I; Papadopoulos C; Karagiannis A; Doumas M
    Diabetes Res Clin Pract; 2019 Dec; 158():107927. PubMed ID: 31733280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardio-renal protection in older people with diabetes with frailty and medical comorbidities - A focus on the new hypoglycaemic therapy.
    Abdelhafiz AH; Sinclair AJ
    J Diabetes Complications; 2020 Sep; 34(9):107639. PubMed ID: 32595017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myocardial infarction in type 2 diabetes using sodium-glucose co-transporter-2 inhibitors, dipeptidyl peptidase-4 inhibitors or glucagon-like peptide-1 receptor agonists: proportional hazards analysis by deep neural network based machine learning.
    Yamada T; Iwasaki K; Maedera S; Ito K; Takeshima T; Noma H; Shojima N
    Curr Med Res Opin; 2020 Mar; 36(3):403-409. PubMed ID: 31855074
    [No Abstract]   [Full Text] [Related]  

  • 8. Primary care management of type 2 diabetes: a comparison of the efficacy and safety of glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors.
    Campos C; Unger J
    Postgrad Med; 2021 Nov; 133(8):843-853. PubMed ID: 34416133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intensifying Treatment Beyond Monotherapy in Type 2 Diabetes Mellitus: Where Do Newer Therapies Fit?
    Kuhn A; Park J; Ghazi A; Aroda VR
    Curr Cardiol Rep; 2017 Mar; 19(3):25. PubMed ID: 28251513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complementing insulin therapy to achieve glycemic control.
    Barnett AH
    Adv Ther; 2013 Jun; 30(6):557-76. PubMed ID: 23797471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Application of new glucose lowering drugs: DPP-4 inhibitors, GLP-1 receptor agonists and SGLT-2 inhibitors].
    Verburg AFE; van den Donk M; Wiersma T
    Ned Tijdschr Geneeskd; 2019 Jan; 163():. PubMed ID: 30676706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Add-on therapy in metformin-treated patients with type 2 diabetes at moderate cardiovascular risk: a nationwide study.
    Thein D; Christiansen MN; Mogensen UM; Bundgaard JS; Rørth R; Madelaire C; Fosbøl EL; Schou M; Torp-Pedersen C; Gislason G; Køber L; Kristensen SL
    Cardiovasc Diabetol; 2020 Jul; 19(1):107. PubMed ID: 32631337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frailty and safety: the example of diabetes.
    Abbatecola AM; Olivieri F; Corsonello A; Strollo F; Fumagalli A; Lattanzio F
    Drug Saf; 2012 Jan; 35 Suppl 1():63-71. PubMed ID: 23446787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New approaches to treating type 2 diabetes mellitus in the elderly: role of incretin therapies.
    Abbatecola AM; Maggi S; Paolisso G
    Drugs Aging; 2008; 25(11):913-25. PubMed ID: 18947259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Newer Glucose-Lowering Therapies in Older Adults with Type 2 Diabetes.
    Bilal A; Pratley RE
    Endocrinol Metab Clin North Am; 2023 Jun; 52(2):355-375. PubMed ID: 36948784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular outcomes associated with SGLT-2 inhibitors versus other glucose-lowering drugs in patients with type 2 diabetes: A real-world systematic review and meta-analysis.
    Li CX; Liang S; Gao L; Liu H
    PLoS One; 2021; 16(2):e0244689. PubMed ID: 33606705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An emerging new concept for the management of type 2 diabetes with a paradigm shift from the glucose-centric to beta cell-centric concept of diabetes - an Asian perspective.
    Saisho Y
    Expert Opin Pharmacother; 2020 Sep; 21(13):1565-1578. PubMed ID: 32521177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New hypoglycaemic therapy in frail older people with diabetes mellitus-phenotypic status likely to be more important than functional status.
    Abdelhafiz AH; Emmerton D; Sinclair AJ
    Diabetes Res Clin Pract; 2020 Nov; 169():108438. PubMed ID: 32920102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [GLP-1 receptor agonists versus SGLT-2 inhibitors in obese type 2 diabetes patients].
    Marques AR; Jaafar J; de Kalbermatten B; Philippe J
    Rev Med Suisse; 2015 Jun; 11(477):1227-8, 1230-3. PubMed ID: 26211282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypoglycaemic therapy in frail older people with type 2 diabetes mellitus-a choice determined by metabolic phenotype.
    Sinclair AJ; Pennells D; Abdelhafiz AH
    Aging Clin Exp Res; 2022 Sep; 34(9):1949-1967. PubMed ID: 35723859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.